DE60233161D1 - Medium zur radikalen therapie von tumoren, von entzündungsprozessen, von pilzinfektionen und von andophylaktische verfahren sowie deren implementierung - Google Patents

Medium zur radikalen therapie von tumoren, von entzündungsprozessen, von pilzinfektionen und von andophylaktische verfahren sowie deren implementierung

Info

Publication number
DE60233161D1
DE60233161D1 DE60233161T DE60233161T DE60233161D1 DE 60233161 D1 DE60233161 D1 DE 60233161D1 DE 60233161 T DE60233161 T DE 60233161T DE 60233161 T DE60233161 T DE 60233161T DE 60233161 D1 DE60233161 D1 DE 60233161D1
Authority
DE
Germany
Prior art keywords
tumors
implementation
medium
inflammatory processes
andophylactic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60233161T
Other languages
English (en)
Inventor
Vladimir Panchev
Marieta Pancheva
Adelina Souvandjieva
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=3928598&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60233161(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60233161D1 publication Critical patent/DE60233161D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/04X-ray contrast preparations
    • A61K49/0409Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60233161T 2001-12-12 2002-04-08 Medium zur radikalen therapie von tumoren, von entzündungsprozessen, von pilzinfektionen und von andophylaktische verfahren sowie deren implementierung Expired - Lifetime DE60233161D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BG106215A BG106215A (bg) 2001-12-12 2001-12-12 Средство за радикално лечение на туморите, възпалителни процеси, гъбични образувания и други изменения на тъканите, диагностика и профилактика и методи за прилагането му
PCT/BG2002/000006 WO2003049728A1 (en) 2001-12-12 2002-04-08 Medium for radical treatment of tumors, inflammatory processes, fungal infections and other affections of the tissues, diagnostic and prophylactic and method of its implementation

Publications (1)

Publication Number Publication Date
DE60233161D1 true DE60233161D1 (de) 2009-09-10

Family

ID=3928598

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60233161T Expired - Lifetime DE60233161D1 (de) 2001-12-12 2002-04-08 Medium zur radikalen therapie von tumoren, von entzündungsprozessen, von pilzinfektionen und von andophylaktische verfahren sowie deren implementierung

Country Status (11)

Country Link
US (1) US20050119344A1 (de)
EP (1) EP1455772B1 (de)
AT (1) ATE437635T1 (de)
AU (1) AU2002245956A1 (de)
BG (1) BG106215A (de)
DE (1) DE60233161D1 (de)
DK (1) DK1455772T3 (de)
EA (1) EA010029B1 (de)
ES (1) ES2332583T3 (de)
PT (1) PT1455772E (de)
WO (1) WO2003049728A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201700154A1 (ru) * 2014-10-20 2017-08-31 Товарищество С Ограниченной Ответственностью "Фармацевтическая Компания "Ромат" Фармацевтический состав лечебно-профилактического действия и способ его приготовления
WO2018192573A1 (zh) * 2017-04-22 2018-10-25 秦才东 一种抑制细胞糖酵解过程的方法及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4147775A (en) * 1976-10-06 1979-04-03 Schwartz Stephen H Antiseptic composition
LU86573A1 (de) * 1986-09-08 1988-04-05 Chimicasa Gmbh Verfahren und praeparat zum inaktivieren von viren innerhalb lebender menschlicher oder tierischer organismen
US4927813A (en) * 1988-03-08 1990-05-22 Bernstein Joel E Method and composition for treating pediculosis capitis
EP0662783B1 (de) * 1992-09-22 1997-07-23 Arda Technologies, Co. Antimikrobielle zusammensetzung und verfahren zu ihrer herstellung
US5879880A (en) * 1996-04-30 1999-03-09 Peregrine Pharmaceuticals, Inc. Method of diagnosing by determining formic acid to nicotinic acid ratio
US6231840B1 (en) * 1998-02-13 2001-05-15 Carol J. Buck Compositions and methods for the topical treatment of nail fungi conditions
SE513436C2 (sv) * 1999-01-21 2000-09-11 Astrid Agholme Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus

Also Published As

Publication number Publication date
EP1455772A1 (de) 2004-09-15
AU2002245956A1 (en) 2003-06-23
ATE437635T1 (de) 2009-08-15
DK1455772T3 (da) 2009-11-30
ES2332583T3 (es) 2010-02-09
WO2003049728A1 (en) 2003-06-19
EA200400783A1 (ru) 2005-04-28
BG106215A (bg) 2003-06-30
EA010029B1 (ru) 2008-06-30
EP1455772B1 (de) 2009-07-29
PT1455772E (pt) 2009-11-03
US20050119344A1 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
BRPI0213786B8 (pt) peptídeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células
DE60135755D1 (de) Verbindungen und methoden zur behandlung von hautverletzungen
ATE401575T1 (de) Zusammensetzungen und verfahren zur diagnose und behandlung von kolonkrebs
BRPI0414455A (pt) métodos para usar células regenerativas no tratamento de doença vascular periférica e distúrbios afins
ATE522623T1 (de) Zusammensetzungen und verfahren zur behandlung und diagnose von lungentumoren
WO2005065242A3 (en) Method of treating cancer using platelet releasate
ATE355852T1 (de) Verwendung von botulinum toxin zur behandlung von herz- und kreislaufskrankheiten
ATE409176T1 (de) 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen
CY1110503T1 (el) Πενταμιδινη για θεραπεια καρκινου
DE60137635D1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
ATE430572T1 (de) Verwendung von spongosin (2-methoxyadenosin) zur behandlung von schmerzen, insbesondere hyperalgesie
ATE415962T1 (de) Verwendung von asiatsäure oder asiaticosid zur behandlung von krebs
ATE336997T1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
DE69838509D1 (de) Verwendung von rekombinanten menschlichen uteroglobin zur behandlung von fibrotischen krankheitszuständen
ATE356995T1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
ATE222101T1 (de) Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
DE60233161D1 (de) Medium zur radikalen therapie von tumoren, von entzündungsprozessen, von pilzinfektionen und von andophylaktische verfahren sowie deren implementierung
DE69932922D1 (de) Verwendung von alkansäuren-enthaltenden zusammensetzungen zur behandlung von nagelpilz-erkrankungen
WO2022271810A3 (en) Bicyclic peptidyl pan-ras inhibitors
WO2004085614A3 (en) Nucleic acid molecules that are differentially regulated in a bipolar disorder and uses thereof
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
HUP0401188A2 (hu) Hiperelágazásos amilopektin sebészeti, gyógyító vagy diagnosztikai eljárásokban emlősöknél való alkalmazásra, különösen plazmatérfogat-növelőként
ATE386029T1 (de) Urokinase-inhibitoren
DE602004030661D1 (de) Verwendung von kahalalide verbindungen zur herstellung eines arzneimittels zur behandlung von psoriasis
DE60021111D1 (de) Verwendung von fibrinolytischen metallproteinasen zur behandlung von blutgerinseln

Legal Events

Date Code Title Description
8364 No opposition during term of opposition